PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22927247-3	2012	Applying liquid chromatography electrospray ionization tandem mass spectrometry, we revealed a significant decrease of proapoptotic ceramide in BCR/IL-4/CD40L-stimulated primary CLL cells compared with untreated controls.	Ceramides	132-140	CD40 ligand	Homo sapiens	153-158	
9315737-2	1997	Here, we provide evidence that activation of T-lymphocytes via CD40L results in activation of a neutral but not an acidic sphingomyelinase correlating with a consumption of sphingomyelin and a release of ceramide.	Ceramides	204-212	CD40 ligand	Homo sapiens	63-68	
8976196-3	1996	Here, we show that human dendritic cells respond to CD40 ligand, as well as to tumor necrosis factor-alpha and IL-1 beta, with intracellular ceramide accumulation, as they are induced to differentiate.	Ceramides	141-149	CD40 ligand	Homo sapiens	52-63	
16545138-8	2006	Co culture with CD40L L cells also blocked the apoptosis induced by exogenous ceramides in breast carcinoma and non Hodgkin"s lymphoma cell lines through a caspase-3-like, 8-like and 9-like dependent pathways.	Ceramides	78-87	CD40 ligand	Homo sapiens	16-21	
16545138-9	2006	CONCLUSION: These results indicate that CD40L expressed on adjacent non tumoral cells induces multidrug resistance to cytotoxic agents and ceramides in both breast carcinoma and non Hodgkin"s lymphoma cell lines, albeit through a caspase independent and dependent pathway respectively.	Ceramides	139-148	CD40 ligand	Homo sapiens	40-45